Background
Photodynamic therapy (PDT) is the use of a light-sensitive drug (a photosensitiser) in combination with light of a visible wavelength, to destroy target cells (e.g. cancerous or pre-cancerous cells). PDT is generally used either as a primary treatment (usually in skin conditions) or as an adjunctive treatment alongside surgery, radiotherapy or chemotherapy. Although PDT is a fairly well accepted treatment in clinical practice for some types of skin lesions, as a treatment for other forms of cancer it has yet to be fully explored. For example each of the nine Interventional Procedure Guidance Documents on PDT issued by NICE between 2004 and 2009 contain some degree of uncertainty over safety and effectiveness.
Objectives
The aim of this project was to systematically review the clinical effectiveness and safety of photodynamic therapy (PDT) in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin.
Methods
An extensive search strategy was developed to include electronic databases, conference abstracts, unpublished studies, contact with experts and manufacturers, and assessment of existing reviews. Published and unpublished studies from any country in any language were eligible for inclusion. Any type of PDT for either curative or palliative treatment was eligible. No restrictions were placed on comparators. The study design criteria depended on the cancer site or condition; randomised controlled trials (RCTs) in skin and Barrett's oesophagus, RCTs and non-randomised controlled trials for all other sites. We also carried out a scoping review of those studies which did not meet the study design criteria according to cancer site/condition. Two researchers independently screened all titles and abstracts, extracted data and quality assessed trials. Discrepancies were resolved by discussion, or referral to a third researcher.
Results
The search strategies identified 12,522 references. Overall 88 trials reported in 141 publications were included, see Figure 1 for details. Some trials covered more than one condition. Duplicate publication of study results and multiple reports of data sets appeared to be common making it more challenging to identify unique data sets. There was generally a paucity of well-conducted, adequately powered RCTs. Quality of life and resource outcomes were underreported.
Clinical effectiveness: Methodological limitations and gaps in the evidence base made the drawing of firm conclusions difficult across the cancer sites and conditions investigated, see Table 1 for a summary of the findings. Further details are available from the full report. 1
Adverse events:
Overall there were no serious adverse events linked to PDT reported. The reported data did not permit a comprehensive comparison of the adverse events profile for each photosensitiser.
Conclusions
Given the limited evidence in most areas it was difficult to draw firm conclusions. Overall PDT appeared to be a promising treatment in the majority of conditions reviewed. However the potential place of PDT amongst the range of other treatments available for each condition is not yet clearly defined. Further high quality research which utilises blinded appropriate outcome measures for clinical responses, and patient-centred outcomes is strongly recommended. PDT was superior to placebo for complete lesion response in RCTs, but its effectiveness against other comparator treatments was uncertain Skin: Bowen's disease PDT may have better outcomes than cryotherapy or fluorouracil for complete lesion response but further research is needed Skin: Basal cell carcinoma Not possible to make any definitive statements for superficial lesions PDT was less effective than surgery in terms of clearance rates for nodular lesions but reported better cosmetic outcomes Barrett's oesophagus Limited evidence suggests PDT plus omeprazole is more effective at long term ablation of high grade dysplasia than omeprazole alone Oesophageal cancer Insufficient evidence to draw firm conclusions of effectiveness Scoping review n = 849 publications *numbers do not total as one publication reported two separate trials, and two trials included multiple distinct patient groups thus were extracted more than once.
Some publications were linked to more than one study.
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